Prognostic Markers of Survival among Japanese Patients with Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer Receiving First-Line Alectinib

The prognoses of patients with non-small-cell lung cancer (NSCLC) harboring anaplastic lymphoma kinase (ALK) gene rearrangement have dramatically improved with the use of ALK tyrosine kinase inhibitors. Although immunological and nutritional markers have been investigated to predict outcomes in pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Takeda, Takayuki, Yamada, Tadaaki, Tanimura, Keiko, Nakano, Takayuki, Ishida, Masaki, Tachibana, Yusuke, Shiotsu, Shinsuke, Horiuchi, Shigeto, Hibino, Makoto, Okada, Asuka, Chihara, Yusuke, Takayama, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699991/
https://www.ncbi.nlm.nih.gov/pubmed/34943412
http://dx.doi.org/10.3390/diagnostics11122170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699991/
https://www.ncbi.nlm.nih.gov/pubmed/34943412
http://dx.doi.org/10.3390/diagnostics11122170

Ejemplares similares